Progesterone Receptor Together with PKCα Expression as Prognostic Factors for Astrocytomas Malignancy.
Denisse Arcos-MontoyaTalia Wegman-OstroskySonia Iliana Mejía-PérezMarisol De la Fuente-GranadaIgnacio Camacho-ArroyoAlejandro Manuel García CarrancáMarco Antonio Velasco VelazquezJoaquín Manjarrez-MarmolejoAliesha González-ArenasPublished in: OncoTargets and therapy (2021)
These results indicate that PR and its phosphorylation at Ser400 site, as well as PKCα and their colocalization, could be considered as possible malignancy biomarkers for astrocytomas grades I-IV.